PSM written testimony regarding Michigan Senate Bills 3, 4, and 5

front page of a document

PSM submits written testimony on Michigan Senate Bills 3, 4, and 5 On April 23, The Partnership for Safe Medicines submitted written testimony in opposition to Michigan Senate Bills 3, 4, and 5, which would create a prescription drug affordability board (PDAB) in Michigan to establish upper payment limits on certain medicines. Read the testimony…

[...]

Prescription Drug Affordability Board Activity through April 16, 2025

Prescription Drug Affordability Board Activity through April 16, 2025 Activities Summary Colorado: Colorado’s PDAB met on April 11, 2025, where it addressed an error in All-Payer Claims Database data and how it affected affordability review information for Enbrel, Cosentyx and Stelara. Maryland: Maryland’s PDAB did not meet in April. Oregon: Oregon’s PDAB met on April…

[...]

FDA Alert: Counterfeit Ozempic found in U.S. Supply Chain

The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the U.S. drug supply chain. The falsified products, labeled with lot number PAR0362 and serial numbers beginning with 51746517, were seized by the FDA on April 9, 2025. Their contents and safety are unverified and pose serious health risks.

[...]

Prescription Drug Affordability Board Activity through March 31, 2025

Prescription Drug Affordability Board Activity through March 31, 2025 Activities Summary Colorado: Colorado’s PDAB cancelled its March meetings. Maryland: Maryland’s PDAB met on March 24, 2025 to begin a cost review of Farxiga and review feedback about updates to PDAB regulations. Oregon: Board members met on March 19, 2025, where they elected a subset of…

[...]